Third Line Medicine: Modern Treatment for Persistent Symptoms

(4)
Third Line Medicine: Modern Treatment for Persistent Symptoms image
ISBN-10:

1850630410

ISBN-13:

9781850630418

Released: Jan 01, 1986
Format: Paperback, 204 pages

Description:

Current medical practice provides two lines of care: First Line Medicine, the basic care provided by primary physicians, and Second Line Medicine, for sophisticated, specialized treatment. When these fail, patients have been left with two options: living with their symptoms, or exploring alternative medicine. Now there is a third option. Third Line Medicine counters the compartmentalization of specialty care by providing an integrated approach which includes both orthodox and alternative treatments - thus offering new hope to the chronically ill and a new direction for modern medicine. --- from book's back cover

Best prices to buy, sell, or rent ISBN 9781850630418




Frequently Asked Questions about Third Line Medicine: Modern Treatment for Persistent Symptoms

You can buy the Third Line Medicine: Modern Treatment for Persistent Symptoms book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $18.98 on Amazon and is available from 2 sellers at the moment.

If you’re interested in selling back the Third Line Medicine: Modern Treatment for Persistent Symptoms book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Third Line Medicine: Modern Treatment for Persistent Symptoms book, the best buyback offer comes from and is $ for the book in good condition.

The Third Line Medicine: Modern Treatment for Persistent Symptoms book is in very low demand now as the rank for the book is 8,233,299 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.